Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis:

Objective:To determine the effect of long-term anti-CD20 B-cell-depleting treatment on regulatory T cell immune subsets that are subnormal in untreated MS patients.Methods:30 clinically stable MS p...